During the past decade, Konstantopoulio General Hospital of Nea Ionia - Agia Olga conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga" #1 sponsor was "Bayer" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Elpen Pharmaceutical Co. Inc." with 1 trials sponsored and "Medtronic Spinal and Biologics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga" are "Heart Failure" (5 trials), "Atrial Fibrillation" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Chronic Pancreatitis" (1 trials). Many other conditions were trialed in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga" in a lesser frequency.

Most popular intervention types in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga" are "Drug" (11 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Neladenoson bialanate (BAY1067197)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Konstantopoulio General Hospital of Nea Ionia - Agia Olga". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Konstantopoulio General Hospital of Nea Ionia - Agia Olga, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Konstantopoulio General Hospital of Nea Ionia - Agia Olga, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".